Filing Details
- Accession Number:
- 0001209191-18-054150
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-03 20:00:25
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-03 20:00:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 876378 | Transenterix Inc. | TRXC | Surgical & Medical Instruments & Apparatus (3841) | 112962080 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1246530 | P Joseph Slattery | C/O Transenterix, Inc. 635 Davis Drive, Suite 300 Morrisville NC 27560 | Evp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-01 | 11,951 | $1.42 | 11,951 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-10-01 | 9,375 | $1.53 | 21,326 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-10-01 | 6,250 | $2.45 | 27,576 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-10-01 | 11,250 | $2.94 | 38,826 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-10-01 | 13,750 | $3.82 | 52,576 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2018-10-01 | 3,575 | $4.02 | 56,151 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-01 | 56,151 | $5.73 | 0 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-10-02 | 8,500 | $1.42 | 8,500 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-10-02 | 8,500 | $5.77 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2018-10-01 | 11,951 | $0.00 | 11,951 | $1.42 |
| Common Stock | Stock Option | Disposition | 2018-10-01 | 9,375 | $0.00 | 9,375 | $1.53 |
| Common Stock | Stock Option | Disposition | 2018-10-01 | 6,250 | $0.00 | 6,250 | $2.45 |
| Common Stock | Stock Option | Disposition | 2018-10-01 | 11,250 | $0.00 | 11,250 | $2.94 |
| Common Stock | Stock Option | Disposition | 2018-10-01 | 13,750 | $0.00 | 13,750 | $3.82 |
| Common Stock | Stock Option | Disposition | 2018-10-01 | 3,575 | $0.00 | 3,575 | $4.02 |
| Common Stock | Stock Option | Disposition | 2018-10-02 | 8,500 | $0.00 | 8,500 | $1.42 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 245,334 | 2027-02-02 | No | 4 | M | Direct | |
| 78,125 | 2026-10-25 | No | 4 | M | Direct | |
| 27,084 | 2025-10-28 | No | 4 | M | Direct | |
| 28,126 | 2025-02-04 | No | 4 | M | Direct | |
| 116,875 | 2026-02-12 | No | 4 | M | Direct | |
| 461,426 | 2024-04-21 | No | 4 | M | Direct | |
| 236,834 | 2027-02-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 25,000 | Indirect | By IRA |
Footnotes
- The transaction occurred pursuant to a written trading plan dated November 29, 2017 meeting the requirements of Rule 10b5-1(c).
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.64 to $5.805 inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.75 to $5.78. inclusive. The reporting person undertakes to provide to TransEnterix, Inc., any security holder of TransEnterix, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.
- Following the sales on October 1, 2018, the reporting person continues to beneficially own 25,000 shares of the company's common stock. The reporting person also holds stock options to acquire 1,749,470 shares of common stock, of which approximately 26% are vested, and restricted stock units representing an additional 595,777 shares of common stock subject to forfeiture restrictions.
- Vests 25% on the first anniversary of the date of grant and 1/48th of the entire award monthly on the vesting date anniversary for 36 months, subject to acceleration as set forth in the Incentive Plan and the reporting person's Employment Agreement with the Company.
- Fully vested.
Billionaire Hedge Funds
